Page: Medicine evaluation figures-2025/4/16

Document: PRAC recommendations on signals adopted at the 5-8 May 2025 meeting-2025/6/2

Page: Availability of medicines before and during crises-2025/7/4

Document: Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars-2025/8/7

Document: Procedural advice on publication of information on withdrawals of marketing authorisation and variation applications for veterinary medicinal products-2025/9/24

Document: Consultation on an ancillary medicinal substance incorporated in a medical device - XVIVO Heart Solution-2025/11/3

Page: Outcomes of imposed non-interventional post-authorisation safety studies-2025/12/2

Document: PRAC recommendations on signals adopted at the 24-27 November 2025 PRAC meeting-2026/1/6

Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)-2026/2/10

Document: Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI)-2026/3/19